Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1249-2021Class II

RNA Medical, Qchgb Hemoglobin Control, Multi, Ref Qc Hgb -

MEDLINE INDUSTRIES, LP - Northfield / initiated 2021-01-25 / Terminated / root cause: manufacturing process

Medline Industries Inc began a recall of RNA MEDICAL, QCHGB HEMOGLOBIN CONTROL, MULTI, REF QC HGB - Product Usage: monitoring the performance of Hemocue Hemoglobin Analyzers. It provides a convenient... on . FDA classified it as Class II and gives the reason as "Product was compromised during shipment". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1249-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
MEDLINE INDUSTRIES, LP - Northfield
Product
RNA MEDICAL, QCHGB HEMOGLOBIN CONTROL, MULTI, REF QC HGB - Product Usage: monitoring the performance of Hemocue Hemoglobin Analyzers. It provides a convenient method of performing periodic QC checks to verify correct system measurement.
Product code
JPK Mixture, Hematology Quality Control
Reason for recall
Product was compromised during shipment.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
The firm notified their consignees by letter on 01/25/2021. The letter explained the problem and requested destruction of the product.
Quantity in commerce
4 units
Distribution
US Nationwide distribution in the states of KY, PA, OH.
Product codes and lots
lot number 072564

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1249-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1249-2021Class IITerminatedVoluntary: Firm initiated